Reaction

Glycosuria reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,335 reports · 48 co-occurring drugs

As of the last recalculation, Glycosuria appears in 1,335 FAERS reports alongside 48 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE TABLETS (PRR 84.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Tenofovir Disoproxil Fumarate Tablets	45	84.1	84.5
Tenofovir Disoproxil Fumarate	122	63.2	63.5
Olanzapine Pamoate	140	59.5	59.7
Atazanavir	41	45.9	46.0
Nevirapine	22	38.6	38.7
Ritonavir	67	37.6	37.7
Ritonavir 100 Mg	35	37.5	37.6
Abacavir Sulfate	23	37.4	37.5
Lamivudine	69	36.7	36.7
Lopinavir And Ritonavir	31	36.5	36.6
Lamivudine Oral	56	36.0	36.1
Ziprasidone Mesylate	27	30.1	30.2
Deferasirox	47	28.6	28.7
Darunavir	24	25.2	25.2
Ziprasidone	27	24.4	24.4
Olanzapine	149	24.2	24.2
Zidovudine	20	23.7	23.7
Efavirenz	16	22.6	22.7
Raltegravir	22	21.1	21.1
Dapagliflozin	40	20.4	20.4
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	11	19.2	19.2
Emtricitabine And Tenofovir Disoproxil Fumarate	54	19.2	19.2
Empagliflozin	77	18.9	18.9
Canagliflozin	33	17.6	17.6
Busulfan	16	16.0	16.0
Lithium Carbonate	17	15.8	15.8
Divalproex Sodium	45	15.6	15.6
Valproic Acid	28	14.1	14.1
Trazodone Hydrochloride	13	13.1	13.1
Baricitinib	8	13.0	13.0
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	8	12.5	12.5
Quetiapine	139	12.4	12.5
Insulin Glargine-Yfgn	17	12.3	12.3
Insulin	42	12.1	12.1
Entecavir	9	12.1	12.1
Pyrazinamide	7	11.7	11.7
Pegaspargase	9	11.5	11.5
Mesna Injection	6	11.4	11.4
Mesna	6	11.2	11.2
Dolutegravir Sodium	6	10.4	10.4
Risperidone	77	9.5	9.5
Ifosfamide	12	8.8	8.8
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	10	8.7	8.7
Emtricitabine And Tenofovir Alafenamide	5	6.9	6.9
Orlistat	8	4.8	4.8
Ledipasvir And Sofosbuvir	5	4.1	4.1
Romosozumab-Aqqg	3	3.5	3.5
Nirmatrelvir And Ritonavir	7	2.0	2.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.